The TAp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia

The TA-isoform of the p63 transcription factor (TAp63) has been reported to contribute to clinical aggressiveness in chronic lymphocytic leukemia (CLL) in a hitherto elusive way. Here, we sought to further understand and define the role of TAp63 in the pathophysiology of CLL. First, we found that el...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood advances 2022-04, Vol.6 (8), p.2646-2656
Hauptverfasser:	Laidou, Stamatia, Grigoriadis, Dionysios, Papanikolaou, Sofia, Foutadakis, Spyros, Ntoufa, Stavroula, Tsagiopoulou, Maria, Vatsellas, Giannis, Anagnostopoulos, Achilles, Kouvatsi, Anastasia, Stavroyianni, Niki, Psomopoulos, Fotis, Makris, Antonios M., Agelopoulos, Marios, Thanos, Dimitris, Chatzidimitriou, Anastasia, Papakonstantinou, Nikos, Stamatopoulos, Kostas
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!